#PLC Controller Programming in new zealand

[rohitpalan]

Lawful Interception Market: Safeguarding Digital Communications

The global lawful interception market is anticipated to secure a market value worth US$ 12.9 Billion while recording a CAGR of 14.8% during the 2022-2032 forecast period, according to a recently published Future Market Insights report. Increasing cases of cybercrimes and the rapid digitalization of firms are anticipated to play a vital role in developing the market in the forecast period.

As per the FBI, U.S citizens lost more than US$ 6.9 Billion to internet crimes in 2021, a jump of more than US$ 2 Billion from 2020. In addition, deployment of 5G networks is gaining significant traction, which is likely to increase cyber-attacks scope across the globe. 5G networks are likely to cover one-third of the globe’s population and also account for approximately 1.2 billion connections by 2025. This is expected to influence the market positively in the forecast period.

Also, the implementation of favorable laws for lawful interception by several governments is expected to augment the market size. Communications Assistance for Law Enforcement Act (CALEA) is one of the laws that features LI standards in the United States.

Get a Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14989

Further, The European Telecommunication Standards Institute (ETSI) and the Third Generation Partnership Project (3GPP) have led the way in standardization. Moreover, with increasing international cooperation between various nations, the market is likely to strengthen. European countries such as New Zealand, Canada, Australia, Canada, and the U.S have played a significant role in strengthening the LI standards.

The surging demand for data-based communication and mobile phone tracking systems to aid security agencies in safeguarding and maintaining consumer interest is another vital cause that is expected to provide avenues of expansion to the market in the forecast period. FamiSafe, Glympse, uMobix, mSpy, and Cocospy are some of the known mobile tracker apps. On the contrary, the intercepted content breaches individuals’ right to privacy and raises ethical concerns, which is likely to inhibit the market growth in the forecast period.

Key Takeaways from the Market Study

Global lawful interception market to surge 4x from 2022-2032

By component, lawful enforcement solutions to expand at a CAGR of 14.6% during the forecast period.

Fixed network lawful interception is expected to dominate, rising at a CAGR of 14.1%

US is projected to garner US$ 4.4 Billion in market value by 2032, reflecting a 14.2% CAGR

China to be an opportunistic investment hub across Asia, reaching US$ 904.7 Million by 2032

Japan is anticipated to grow at a CAGR of 13.3% during the forecast period

“Increasing cyberattacks and rising initiatives, especially by developing countries, to strengthen cybersecurity, are likely to favor market growth in the future,” remarks an FMI analyst.

Competitive Analysis

Key players in the global lawful interception market include VOCAL Technologies Ltd, Utimaco, Aqsacom Incorporated, BAE Systems plc, and Verint Systems. Notable developments in the market are as follows

In June 2022, Utimaco announced that it had successfully closed the investment round with SGT Capital, its new owner. SGT Capital’s ownership of Utimaco has obtained all mandated regulatory approvals, such as Committee on Foreign Investment in the United States (CFIUS), Energy and Industrial Strategy, the United Kingdom’s Department for Business, and Germany’s Federal Ministry for Economic Affairs and Climate Protection.

In May 2022, BAE Systems received a contract worth US$ 24 Million from the U.S Defense Advanced Research Projects Agency (DARPA) to develop software that independently configures tactical networks for mission-critical communications as part of the Mission-Integrated Network Control (MNIC) program. MNIC aims to demonstrate an integrated system that offers a secure path for communication to assist multi-domain operations.

Ask for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14989

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global lawful interception market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.

[bhandvalkar94]

Global Antibiotic Resistance Market to Grow at 4% CAGR during 2021-2029

When microbes evolve biological mechanisms that can protect them from elimination by antimicrobial, the danger of antimicrobial resistance (AMR) is visible. AMR are drug-resistant pathogens whose spread is a growing public health concern in many countries. The growth of resistant bacteria usually happens due to overuse of antibiotics, or due to their use being different from what has been prescribed. This renders antibiotics less effective or ineffective. It is believed that by 2050, AMR infections may cause 10 million deaths annually. Increase in hospitalizations and increasing use of antibiotics in COVID-19 treatment are expected to further exacerbate AMR. Hence, the market for antibiotic resistance research and medicines useful for treatment is expected accelerate in the near future.

Tuberculosis (TB) is one of the most dangerous infectious diseases from a single infectious agent and its virus has developed significant antibiotic resistance in the modern times. Multidrug-resistant TB (MDR-TB) is considered a global public health emergency by the World Health Organization. According to 2017 estimates, 465,000 cases of TB were estimated worldwide. 38% people were eligible for MDR/Rifampicin-resistant (RR)-TB. 57% of MDR/RR-TB cases received successful treatment. Mylan has also secured approval from Drugs Controller General of India (DCGI) for Pretomanid, which is useful for treatment for highly drug-resistant forms of tuberculosis. Johnson & Johnson has been in the business of developing and responsibly deploying innovative technologies and treatments to combat the growing threat of AMR on multiple fronts.

Request a sample Copy@

https://www.absolutemarketsinsights.com/request_sample.php?id=876

The major factor driving the growth of global antibiotic resistance market is the growing prevalence of hospital-acquired infections. Antibiotic resistant bacteria can spread from person to person in the community. Implementing precautionary infection control procedures can minimize spread of such bacteria in hospitals. From person to person, usually this infection spreads from contact with either contaminated hands of hospital staff, or contaminated surfaces such as door handles, over-bed tables and call bells. Sometimes it also spreads due to contact with contaminated equipment that includes stethoscopes and blood pressure cuffs.

Strategic investments coupled with favorable initiatives by regulatory authorities showcases significant opportunities for the growth of global antibiotic resistance market over the period of next eight years. The Food and Drug Administration (FDA) of the United States of America (USA) and the Centers for Disease Control (CDC) in USA have launched several initiatives to help address antibiotic resistance. FDA is also encouraging new research into effective diagnostic tests, antibiotic regimens, and vaccines. Under qualified infectious disease product (QIDP) program, which is meant to encourage antibiotic development, FDA has also approved new and innovative antibiotics for resistant infections. Such antibiotics include Arikayce (amikacin liposome inhalation suspension), Baxdela (delafloxacin), Nuzyra (omadacycline), Pretomanid, Recarbrio (cilastatin, imipenem, & relebactam), Xerava (eravacycline), and Xepi (ozenoxacin).

The different variants of the coronoavirus has had severe impact on patients. Increased dosage of antibiotics are being prescribed to COVID patients who developed co-infections (bacterial with coronavirus). Increased investments into research and development initiatives towards adequate treatment of the same is anticipated to propel the growth of global antibiotic resistance market over the forecast period.

Enquiry Before Buying@

https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=876

 Key Findings of the Report:

·         The global antibiotic resistance market was valued at US$ 8417.36 Mn in 2020 growing at a CAGR of 4% over the forecast period (2021 – 2029).

·         The carbapenem-resistant enterobacteriaceae (CRE) category in the global antibiotic resistance market held the larger market share in 2020. Carbapenem-resistant enterobacteriaceae (CRE) are a family of bacteria that are very difficult to treat due to their highly resistant nature towards antibiotics. They have a reputation of adapting to different types of antibiotic treatments and develop resistance towards them.

·         The complicated urinary tract infections (cUTI) category in the global antibiotic resistance market held the larger share in 2020. Urinary tract infections (UTIs) are considered to be one of the most common types of infections. According to studies, at least one in two women and one in 10 men experience UTI in their life period.

·         Antifolates segment occupied the largest market share in the global antibiotic resistance market in 2020. Antifolate drugs are helpful in the treatment of communicable and infectious diseases such as malaria. Many bacteria and viruses that have developed antibiotic resistance spread diseases similar to malaria, such as dengue and other mosquito-borne diseases.

·         In 2020, North America dominated the global antibiotic resistance market. Availability of advanced medical sector, increasing prevalence of infectious diseases, presence of major market players, numerous drug launches in the market, and rising growth in the pharmaceutical sector amongst other factors have contributed towards the region’s highest share. Infectious Diseases Society of America (IDSA) has approved the use of many new drugs that are expected to offer successful treatment against bacteria and viruses that have developed antibiotic resistance.

·         Some of the major players operating in the global antibiotic resistance market are Allergan Pharma Co., GlaxoSmithKline PLC., Johnson & Johnson Services Inc., MELINTA THERAPEUTICS - THE ANTIBIOTICS COMPANY, Merck & Co. Inc., Mylan N.V., Nabriva Therapeutics PLC, Otsuka Novel Products GmbH, Pfizer Inc., and Sandoz AG amongst others.

Request for Customization@

https://www.absolutemarketsinsights.com/request_for_customization.php?id=876

Global Antibiotic Resistance Market:

·         By Resistant Bacteria Type

o   Pseudomonas Aeruginosa

o   Clostridioides difficile (C. difficile)

o   Carbapenem-resistant Enterobacteriaceae (CRE)

o   Streptococcus pneumoniae (S. pneumoniae)

o   Acinetobacter

o   Vancomycin-resistant Enterococci (VRE)

o   Mycobacterium Tuberculosis (TB)

o   Neisseria gonorrhoeae (N. gonorrhoeae)

o   Others

 ·         By Disease Indication

o   Complicated Urinary Tract Infections (cUTI)

o   Complicated Intra-Abdominal Infections (cIAI)

o   Community-Acquired Bacterial Pneumonia (CABP)

o   Acute Skin and Skin Structure Infections (ABSSSI)

o   Multidrug-Resistant (MDR) and Pulmonary Extensively Drug Resistant (XDR) Tuberculosis (TB) (MDR-TB and XDR-TB)

o   Sepsis

o   Clostridium Difficile (C. difficile) Infections

o   Others

 ·         By Drug Class

o   Antimycobacterials

o   Fluoroquinolones

o   Oxazolidinones

o   Tetracyclines

o   Penicillins

o   Antifolates

o   Combination Treatment

o   Others

 ·         By Route of Administration

o   Oral

o   Topical

o   Intramuscular

o   Intravenous (IV)

 ·         By End Use

o   Home Care

o   Healthcare Facilities

o   Others

 ·         By Region

o   North America

§  U.S.

§  Canada

§  Mexico

§  Rest of North America

o   Europe

§  France

§  The UK

§  Spain

§  Germany

§  Italy

§  Nordic Countries

·         Denmark

·         Finland

·         Iceland

·         Sweden

·         Norway

§  Benelux Union

·         Belgium

·         The Netherlands

·         Luxembourg

§  Rest of Europe

o   Asia Pacific

§  China

§  Japan

§  India

§  New Zealand

§  Australia

§  South Korea

§  Southeast Asia

·         Indonesia

·         Thailand

·         Malaysia

·         Singapore

·         Rest of Southeast Asia

§  Rest of Asia Pacific

o   Middle East & Africa

§  Saudi Arabia

§  UAE

§  Egypt

§  Kuwait

§  South Africa

§  Rest of Middle East & Africa

o   Latin America

§  Brazil

§  Argentina

§  Rest of Latin America

For More Information Click@ https://www.absolutemarketsinsights.com/reports/Antibiotic-Resistance-Market-2021---2029-876

About Us: Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:

Company: Absolute Markets Insights Email id: sales@absolutemarketsinsights.com  Phone: +91-740-024-2424 Contact Name: Shreyas Tanna The Work Lab,Model Colony, Shivajinagar, Pune, MH, 411016 Website: https://www.absolutemarketsinsights.com/

[researchetcsblog]

Key Trends in the Global Pharmaceutical Industry

Global "drug safety Solutions and Pharmacovigilance" (2021) survey spins the tale of drug safety solutions worldwide with paramount data, for instance, salary and contact details, costs, division, driving factors, profile of key organizations, restrictions, reasons behind licensing, analysis, market sector, shares and profits by drug manufacturers. In addition to global drug safety solutions and pharmacovigilance markets, there are also other important drug safety solutions such as drug safety products, drug safety training programs, drug development, drug safety distribution, medical device regulation, quality systems etc. As they show, drug safety solutions are offered in a variety of forms such as pharmaceuticals, nutrition, healthcare products, personal protective equipment, medicines, drug safety devices etc. The drug safety solutions market is indeed a global one and drug manufacturers from every country strive to meet the safety standards.

The Pharmaceutical Research Industry (PRI) is the engine behind drug safety solutions and pharmacovigilance market is gaining momentum. With global health issues on the rise, drug discovery is essential for overcoming these issues. It also helps in developing new drug products that fight against dangerous drug compounds. PRI helps in drug safety solutions and pharmacovigilance markets is booming too.

Among major players operating in drug safety solutions research and pharmacovigilence market are Biogen, Novartis, Merck, and Janssen Pharmaceuticals. Biogen, a part of the "GH drug discovery alliance", is involved in clinical trials on Alzheimer's disease and depression. It has also signed a raft of Memorandums of Understanding with the FDA (Food and Drug Administration). In this way, it ensures maximum participation of the patients in the drug safety solutions and pharmacovigilence market. It also takes strong initiatives to provide enough safety data through frequent drug safety conferences and drug safety meetings.

Another drug producer, Novartis, is focusing on drug development for cardiovascular conditions, diabetes and rheumatoid arthritis. It also aims at meeting the demands of the global market by producing new drug products that fight against chronic obstructive pulmonary disease and sleep apnea. A promising drug product called "Biosource" from Janssen is expected to meet the challenge of revenue maximization.

The market demand for drugs is increasing exponentially due to ageing population and improved general health. The drug safety solutions and pharmacovigilence market is witnessing tremendous revenue growth with an average annual growth rate of about 5%. The drug product revenues are likely to witness growth rate of more than 20% in coming years. However, drug manufacturing companies face a lot of challenges like oversupply of raw materials and production costs. To tackle these issues, the drug developing countries like India is focusing on drug manufacturing capacity building.

The drug manufacturing industry is investing huge amounts of money in research and development, infrastructure development and scale-up. These efforts have resulted in major drug product innovations that have reduced drug safety risk and improved the profitability of drug production. However, the drug products that have been manufactured at large scale still faces many challenges in terms of cost control and market size. The key to successful drug business is identification of target profit and minimizing the cost of production through timely development, scale-up and research.

Global antibiotics market will reach $63.99 billion by 2030, growing by 3.5% annually over 2020-2030 driven by rising incidences of bacterial infection, growing awareness and need for new drugs and treatment amid the COVID-19 epidemic.

Highlighted with 86 tables and 93 figures, this 182-page report “Global Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region.

Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Cephalosporin

• Penicillin

• Macrolides

• Fluoroquinolones

• Quinolones

• Monobactam

• Aminoglycosides

• Carbapenem

• Other Drug Classes

Based on Action Mechanism, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Cell Wall Synthesis Inhibitors

• Mycolic Acid Inhibitors

• RNA Synthesis Inhibitors

• DNA Synthesis Inhibitors

• Protein Synthesis Inhibitors

• Other Mechanisms

Based on Drug Origin, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Natural Antibiotics

• Semi-synthetic Antibiotics

• Synthetic Antibiotics

Based on Activity Spectrum, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Broad-spectrum Antibiotics

• Narrow-spectrum Antibiotics

Based on Route of Administration, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Oral Administration

• Intravenous Administration

• Other Administration Routes

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Brand Antibiotics

• Generic Antibiotics

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

• North America (U.S., Canada, and Mexico)

• South America (Brazil, Chile, Argentina, Rest of South America)

• RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Class, Drug Origin, and Route of Administration over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global antibiotics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

Astellas Pharma

AstraZeneca Plc

Bayer AG

Bristol Myers Squibb Company

Cipla Inc.

Dr. Reddy’s Laboratories Ltd.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gilead Sciences, Inc.

GlaxoSmithKline plc.

Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)

Mayne Pharma Group Ltd.

MELINTA THERAPEUTICS, INC.

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Global Antibiotics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.

North America Antibiotics Market

Europe Antibiotics Market

Asia Pacific Antibiotics Market

Global Oral Antibiotics Market

Contact us: https://www.reportmines.com/contact-us.php 

[adityarana1687-blog]

Meningococcal Vaccine Market Estimated To Value $5.9 Billion By 2027

The global meningococcal vaccine market size is expected to reach USD 5.9 billion by 2027, expanding at a CAGR of 9.5%, according to a new report by Grand View Research, Inc. Increasing prevalence of meningitis is one of the major factors attributed to the market growth. Furthermore, according to the European Centre for Disease Prevention and Control (ECDC), it was estimated that in 2017, 3,221 confirmed cases were observed in the EU member states, in which 58% of cases were found in the U.K., France, Spain, and Germany.

In addition, manufacturers are receiving Break Through Designation (BTD) for the development of improved vaccines as compared to available therapy. For instance, in February 2018, GlaxoSmithKline plc received BTD for Bexsero for extending its use in the age group below 11 years. Such initiatives are expected to improve meningococcal prevention, which in turn is anticipated to drive the market.

Initiatives undertaken by the government to combat the rising incidence of the disease is anticipated to boost the market growth. For instance, from April 2019, Nimenrix was made available for free as a part of the National Immunisation Program (NIP) for the age group 14 to 16 years. Nimenrix is a single dose quadrivalent meningococcal vaccine that targets serogroups A, C, W & Y.

In addition, rising awareness programs focused on prevention of the target disease is expected to fuel market growth. For instance, in April 2019, the National Day of Action against Meningitis B was launched by the Meningitis B Action Project on World Meningitis Day to improve awareness of meningitis regarding available vaccines such as MenACWY and MenB among healthcare professional, students, and parents.

Furthermore, the government provision of free vaccination to reduce the spread of the target disease is anticipated to boost the market growth. For instance, in November 2018, the government of New Zealand started a free vaccination program in Northland for infants and children.

Non-profit organizations entering into strategic initiatives such as partnering, alliances, and others to improve access to new vaccines for vulnerable children is anticipated to drive the market. For instance, Gavi is a vaccine alliance formed between UNICEF, World Health Organization, the Bill and Melinda Gates Foundation, and the World Bank to help boost economies of low-income countries and improve access to under-used vaccines for children suffering from meningitis.

Moreover, clinical trials conducted on teenagers to develop novel meningococcal vaccines are expected to drive the market. For instance, in March 2018, the National Health Service launched a Meningitis B vaccine trial for teenagers and recruited 24,000 volunteers of age group 16 to 18 years for this study. This clinical trial was funded and supported by the National Institute for Health Research (NIHR).

The availability of vaccines at lower prices in countries with an increasing prevalence of meningococcal diseases is anticipated to fuel the revenue of the manufacturers and drive the market. For instance, under the Meningitis Vaccine Project, MenAfriVac costs less than USD 0.5 per dose.

Request a free sample copy or view report summary: Meningococcal Vaccine Market Report

Meningococcal Vaccine Market Report Highlights

In 2019, Bexsero was the largest-revenue holding brand in the market owing to its stronger demand in Europe and studies showing a decrease in meningitis cases

The quadrivalent segment is expected to witness the fastest growth over the forecast period due to its ability to target four serogroups and the availability of vaccines such as Menactra, Menveo, and Nimenrix

In the case of the age group segment, infants (0 to 2 years) are expected to witness a significant CAGR owing to the increasing prevalence of meningitis in the age group 9 months to 11 years

Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and rising healthcare expenditure

North America dominated the market in 2019 due to the presence of key players and rising initiatives to raise awareness among healthcare professionals and patients

Meningococcal Vaccine Market Segmentation

This report forecasts revenue growth at global, regional, and country and provides an analysis of the latest industry trends in each of the sub-markets from 2016 to 2027. Grand View Research has segmented the global meningococcal vaccine market on the basis of type, brand, age group, and region:

Meningococcal Vaccines Type Outlook (Revenue, USD Million, 2016 - 2027)

Bivalent

Quadrivalent

Others

Meningococcal Vaccines Brand Outlook (Revenue, USD Million, 2016 - 2027)

Menactra

Menveo

Nimenrix

Trumenba

Bexsero

Others

Meningococcal Vaccines Age Group Outlook (Revenue, USD Million, 2016 - 2027)

Infants (0 to 2 years)

Children and Adults (2 years and above)

Meningococcal Vaccines Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

The U.S

Canada

Germany

The U.K.

France

Italy

Spain

Russia

Japan

China

India

Australia

Singapore

South Korea

Brazil

Mexico

Argentina

Saudi Arabia

South Africa

UAE

List of Key Players of Meningococcal Vaccine Market

Pfizer Inc.

Novartis AG

Sanofi

Serum Institute of India Ltd.

GlaxoSmithKline plc.

Merck & Co., Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

[mellowfartpost]

Telecom API Platform Market to Grow Rapidly as United States and Canada Region Creates Significant Opportunities for Market Players

The Global Telecom API Platform Market report offers industry overview including definitions, applications, classifications, and chain structure. The report provides a comprehensive assessment of the studied market, including key trends, historic data, current market scenario, opportunities, growth drivers, potential roadmap, and strategies of the market players.  The report further includes regional analysis to evaluate the global presence of Telecom API Platform Market.

In order to simplify the industry analysis and forecast estimation for the Telecom API Platform Market, our research report delivers well-defined market scope and systematically developed research methodology.

An application programming interface (API) is also referred to as middleware; is a set of standard software functions designed for process efficiency. API is the interface between the device's resource and the app it is used on. The API is used to create services and applications that are free from the limits of the device on which the program is running. Telecom APIs enable application developers to build up services such as payment, SMS, and webRTC on their mobile applications, resulting in increased user-specific procedures, improved customer experience, and increased adoption of their applications. Huge investments are made by telecommunications carriers to set up their own API platform in a corporation with aggregators and service providers with a view to maximizing profits. Telecom carriers may face challenges from over-the-top (OTT) service providers.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.kdmarketinsights.com/sample/6657

Segmentation

By Type

SMS, MMS, and RCS API

Web RTC API

Payment API

Content Delivery API

ID/SSO and subscriber API

IVR/voice store and voice control API

M2M and IoT API

Location API

Others

By End Use

Enterprise developer

Internal developer

Partner developer

Long tail developer

REGIONAL INSIGHT:

North America (the United States and Canada).

Latin America (Brazil, Mexico and Rest of Latin America).

Asia Pacific (China, India, South Korea, Indonesia, Japan, Australia, New Zealand and Rest of Asia Pacific).

Europe (Germany, United Kingdom, Italy, France, Russia, Spain and Rest of Europe).

Middle East and Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa and Rest of the Middle East and Africa).

Request Discount on this Report @ https://www.kdmarketinsights.com/discount/6657

Key Questions Answered in the Global Rolling Stocks Industry Report

What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2025?

Which region would have high demand for product in the upcoming years?

What are the factors driving the growth of the market?

Which sub-market will make the most significant contribution to the market?

What are the market opportunities for existing and entry-level players?

What are various long-term and short-term strategies adopted by the market players?

Competitive Landscape

The report profiles various major market players such as

Vodafone Group PLC

Aspect Software

Twilio Inc.

Alcatel-Lucent

AT&T Inc.

Apigee Corporation

Orange S.A.

Verizon Communications Inc.

Tropo Inc.

Other Major & Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities). The study also provides company’s positioning and market share of the overall market.

Request For Customization – https://www.kdmarketinsights.com/custom/6657

Why KD Market Insights?

We use latest market research tools and techniques to authenticate the statistical numbers

Availability of customized reports

Expert and experienced research analysts in terms of market research approaches

Quick and timely customer support for domestic as well as international clients

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant, and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com

More update - kdmidive.com

[instanttimetravelnut]

Increasing Consumer Awareness to Fuel Adoption of Iot Gateway Market

IOT Gateway Market: Introduction

Increased demand for Big Data analytics is changing the IoT gateway market to an extent in recent days. The demand of analytics boost the demand for IoT gateway in the market, as Big Data helps analyzing sensor data and starts data collection for many of the industrial machines, such as oil refineries, turbines and others. Moreover, it help organizations in optimizing their business decisions and innovating new business models, products, and service offerings.

An IoT gateway is a physical device or software program that serves as the connection point between cloud and controllers, sensors, and intelligent devices. All data moving to the cloud or vice versa, goes through the gateway, which can be either a dedicated hardware appliance or software program. An IoT gateway may also be referred to as an intelligent gateway or a control tier.

To remain ‘ahead’ of your competitors, request for a sample here@ https://www.persistencemarketresearch.com/samples/20182

IoT Gateway Market: Drivers and Challenges

Some of the drivers for the IoT Gateway Market are improved internet connectivity in technologically advancing countries, and increased IP address space and security solutions provided in IPv6. The main feature cum driver for the IoT Gateway market is that it nullifies the security glitch of cloud by some value by providing its own level of security.

One of the restraint for IoT Gateway Market is that the designing of this IoT gateway is complex and need skilled professionals for designing, which is not the case always.

IoT Gateway Market: Segmentation

The IoT Gateway Market can be segmented on the basis of end user, application, and region.

On the basis of end user the IoT Gateway Market can be divided into;

Process Industry

Discrete Industry

This segment showcase industries in which the network traffic analyzers are going to be used or by whom these network traffic analyzers are going to be used.

On the basis of application the IoT Gateway Market can be segmented into;

Remote monitoring

Preventive maintenance

Production optimization

This segment reflects, that in which particular applications IoT gateway can be used and the network traffic analyzer is available in the market.

IoT Gateway Market: Key Players

Some of the key players of IoT Gateway Market are: NXP Semiconductors N.V., Intel Corporation, Mitsubishi Electric Corporation, ARM Holdings, Plc, Super Micro Computer, Inc. and others.

IoT Gateway Market: Regional Overview

On the basis of geography, IoT Gateway Market can be segmented across North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. Among various regions, the IoT Gateway Market in North America is expected to dominate during the forecast period, owing to many companies present in the region for IoT gateways. North America region is expected to be followed by Asia Pacific, and Europe.

For critical insights on the keyword market, request for methodology here @ https://www.persistencemarketresearch.com/methodology/20182

The report covers exhaustive analysis on:

IoT Gateway Market Segments

IoT Gateway Market Dynamics

Historical Actual Market Size, 2012 – 2016

IoT Gateway Market Size & Forecast 2017 To 2027

Supply & Demand Value Chain

IoT Gateway Market Current Trends/Issues/Challenges

Competition & Companies involved

IoT Gateway Market Value Chain

IoT Gateway Market Drivers and Restraints

Regional analysis for IoT Gateway Market includes

North America Market

Latin America Market

Western Europe Market

Eastern Europe Market

Asia Pacific Excluding Japan Market

Japan Market

Middle East and Africa Market

U.S.

Canada

Argentina

Mexico

Brazil

Rest of Latin America

Germany

France

U.K.

Spain

Italy

Nordic

Benelux

Rest of Western Europe

Poland

Russia

Australia and New Zealand (A&NZ)

China

India

ASEAN

Rest of Asia Pacific

GCC Countries

North Africa

South Africa

Rest of MEA

The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market

Changing market dynamics of the industry

In-depth market segmentation

Historical, current and projected market size in terms of value

Recent industry trends and developments

Competitive landscape

Strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

A neutral perspective towards market performance

Must-have information for market players to sustain and enhance their market footprint

Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/20182

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor New York City, NY 10007 United States

Ph.no. +1-646-568-7751

E-mail id- sales@persistencemarketresearch.com

Website: https://www.persistencemarketresearch.com

[renegadeelectrics]

Renegade Electrics - Automation + Control Limited - PLC Controller Programming in New Zealand

Renegade Electrics introduces Modicon PLC Controllers in New Zealand, revolutionizing automation with precision and reliability. Trust our cutting-edge solutions to optimize your operations efficiently. Elevate your control systems with Renegade Electrics - Automation + Control Limited.

[nicolasmatamoros6675]

Safety Programmable Logic Controller Market Size Progresses for Huge Profits During 2019-2030

Safety Programmable Logic Controller Market: Introduction to programmable logic controllers

A programmable logic controller is an industrial digital computer that has been toughened up to adapt for the control of diverse manufacturing processes such as robotic devices or assembly lines, or any other activity that necessitates ease of programming, process fault diagnoses and high-reliability control. All controllers available in the programmable logic controller market essentially serve the same purpose i.e. controlling some mechanical process. The most common programmable logic controller functions are control, sequencing and timing of actions such as turning pumps, valves or motors on or off.

Safety Programmable Logic Controller Market: Difference between standard and safety programmable logic controllers

A safety programmable logic controller is a dedicated controller specially built to meet certain safety requirements such as the ISO 13849-1, IEC 62061 and IEC 61508 functional safety directives that define the Safety Integrity Level or the risk reduction level enabled by a particular safety function. There are several important differences at the hardware level between the physical programmable logic controller and the safety logic controller. The main difference between the two is the presence of self-checking and redundancy mechanisms in the safety programmable logic controllers that are not found in the standard programmable logic controller. Another key difference is in the input and output stage. In the case of the former, a safety programmable logic controller continuously keeps track of the input status to identify and malfunctions or failures that could indicate a problem in the machine itself or sometime in the future. In the latter case, there is additional safety circuitry between a connected device and the output meant to limit the damage to the external device in the event of any fault of malfunction.

Request A Sample Copy Of The Report https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32738

So how can it be decided if an organisation needs a regular programmable logic controller or a safety programmable logic controller? Typically, the machine safety requirements are understood in one of two ways; by the safety regulations governing machines in the country where it is going to be used or on the basis of the machine type designed. For e.g.- there are substantial machine safety requirement differences between the U.S. and the E.U. or between the E.U. and China. Even machines deployed in the food and beverage industry, a stamping press controller, or an oil refinery controller have different safety requirements that must be taken into account.

The four main categories available in the safety programmable logic controller market are –

Category 1 – Lowest category safety circuit. Single channel relay to safety

Category 2 – Two channel safety circuit. The first channel is hardwired to an e-stop chain while the second channel can be either the PLC monitoring on safety switch auxiliary contact or another hardwire

Category 3 – Two hardwired channels in a safety circuit. Those drives that have a ‘safe off’ feature are included in this category

Category 4 – Two hardwired channels for a safety circuit with a safety relay that is self-monitoring. Category 4 is the toughest category and is the most popular in the automobile industry.

Safety Programmable Logic Controller Market: Advantages and disadvantages of safety programmable logic controllers

The main advantages of a safety programmable logic controller are –

Major savings in the field wiring, particularly in safety categories 3 and 4

Highly flexible and scalable

Remote I/O capability with an added element of safety

Standard and safety controls in one unit

Adequate diagnostic capability

Perfect for many e-stop zone applications

There few disadvantages of safety programmable logic controller are –

Higher upfront cost

Requires a certain degree of programming

Slightly complex for some applications

Requires maintenance experts with specialized skills

Safety Programmable Logic Controller Market: Companies

A few of the most prominent companies in the safety programmable logic controllers market are Siemens, Pilz Automation Safety, Rockwell Automation Inc, ABB, and Yacoub Automation GmbH.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments

Market trends and dynamics

Supply and demand

Market size

Current trends/opportunities/challenges

Competitive landscape

Technological breakthroughs

Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)

Latin America (Mexico, Brazil, Peru, Chile, and others)

Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)

Eastern Europe (Poland and Russia)

Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)

Middle East and Africa (GCC, Southern Africa, and North Africa)

Request For Covid19 Impact Analysis https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=32738

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market

Important changes in market dynamics

Market segmentation up to the second or third level

Historical, current, and projected size of the market from the standpoint of both value and volume

Reporting and evaluation of recent industry developments

Market shares and strategies of key players

Emerging niche segments and regional markets

An objective assessment of the trajectory of the market

Recommendations to companies for strengthening their foothold in the market

[marketfuturereports]

Contraceptives Market Trends, Industry Survey, Overview and Forecast till 2025

02nd January 2019 - Global Contraceptives Market is classified on the basis of drugs, medical device, end users, distribution channel and geography. Medicines and medical devices that are utilized in order to prevent unwanted pregnancy are known as contraceptives. These contraceptives basically act by blocking the regular process of fertilization, ovulation, etc. There are different types of contraceptives with different mode of action, such as intrauterine device (IUD), sterilization, barrier methods such as condoms, diaphragms, etc. and hormonal methods such as pills. On the flip side, there are also a number of risks associated with the use of contraceptives such as risk of pelvic infection, incorrect use of condoms, formation of blood clots due to consumption of contraceptive pills, etc.

Request a Sample Copy of Contraceptives Market Report @ https://www.millioninsights.com/industry-reports/contraceptives-market/request-sample

Factors propelling the market growth comprise rising awareness among people and high-tech innovations. In addition, ever increasing population and therefore a necessity to control the population. Moreover, a number of programs are being conducted by the government as well as a NGO’s to put forward the use of contraceptives. Furthermore, factors such as growing prevalence of sexually transmitted diseases is also fuelling the growth of the Contraceptives Market. On the other hand, there are certain factors that may hamper the growth of the market such as side effects associated with use of contraceptives and also increasing prevalence of infertility cases in women.

Contraceptives Market is classified on the basis of drugs as oral contraceptive pills, contraceptive injectable, topical contraceptives. Based on medical device, the global market is bifurcated into male contraceptive devices and female contraceptive devices. Male contraceptive devices consist of male condoms. Whereas, female contraceptive devices consist of female condoms, contraceptive vaginal rings, sub-dermal contraceptive implants, contraceptive diaphragm, intrauterine devices, contraceptive sponges and non-surgical permanent contraception device. Contraceptives Market is classified on the basis of end users as clinics, hospitals, home care, ambulatory surgical centres and others. Based on distribution channel the global market spans hospital pharmacy, retail pharmacy, e-commerce, online pharmacy and others.

Key Vendors

• Merck

• Cipla Inc.

• Allergan plc

• Bayer AG

• HLL Lifecare Limited

• Mankind Pharma

• Pfizer, Inc.

• Teva Pharmaceutical Industries

• Mithra Pharmaceuticals and many others

Segmentation based on Product Types

• Oral Contraceptive Pills

• Contraceptive Injectable

• Topical Contraceptive Patch

Segmentation based on Applications

• Hospitals Pharmacy

• Independent Pharmacy

• Online Platform

• Clinics

• Others

Access Contraceptives Market Report with TOC @ https://www.millioninsights.com/industry-reports/contraceptives-market

Contraceptives Market is geographically classified on the basis of as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa. The North American region consists of the U.S., and Canada. Latin America region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia & New Zealand. The Middle East and Africa region consists of GCC, South Africa and North Africa. In case of geographical region, North America is projected to account a major share of the Contraceptives Industry. The factors that attribute to the growth of this region is owed to presence of favourable reimbursement policies and growing usage of oral contraceptive pills.

On the other hand, Asia Pacific is expected to be the fastest growing region and show strong growth rates in the global market. The factors that contribute to the growth of this region is due to ever increasing population, awareness among people, rising use of contraceptives, etc.

[rishabh3210blog]

Global Seasonal Affective Disorder Therapeutics Market Size, Share & Forecast To 2020-2026

The global seasonal affective disorder therapeutics market is estimated to witness significant growth during the forecast period. Rising mental health awareness programs are primarily contributing to market growth. Governments of the countries have witnessed a major role to promote education about the mental conditions among people.  As per the World Health Organization (WHO), 87% of all western pacific countries have a minimum of two active programs related to mental health prevention and promotion. Western Pacific countries include China, Australia, Singapore, Japan, New Zealand, and more.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/seasonal-affective-disorder-therapeutics-market

As per the estimates by WHO, over 300 million people globally have depression, a rise of more than 18% during the period, 2005 and 2015. The 2017 "Let's talk" campaign aims that more people suffering from depression globally, have access to treatment. It promotes workplace mental health and developing comprehensive prevention strategies for suicide. Further, as per the data published by the WHO in October 2019, nearly 54 million people in China have depression, and nearly 41 million have anxiety disorders.

A Full Report of Global Seasonal Affective Disorder Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/seasonal-affective-disorder-therapeutics-market

Healthy China 2019-2030 targets comprise 80% of patients with depression have treatment access by 2030 (and a minimum of 30% by 2022). This increasing focus on leverage access to treatment is expected to drive the demand for seasonal affective disorder treatment. The seasonal affective disorder is a form of depression which is associated with changes in seasons that start and ends at nearly the same times every year. Treatment for seasonal affective disorder comprise medications and light therapy (phototherapy). Light therapy is gaining significance for the treatment of the seasonal affective disorder. In light therapy, the patient sits or work near a light therapy box, which emits a bright light that imitates natural outdoor light.

Light therapy is expected to affect brain chemicals associated with mood and sleep, that provides ease from seasonal affective disorder symptoms. It may also support in sleep disorders, other kinds of depression, and other disorders. Light therapy is also referred to as phototherapy or bright light therapy. Innovations in light therapy have been reported, which is offering an opportunity for the growth of the market. For instance, in February 2019, Active Wearables, an Austrian Medtech startup launched Pocket Sky, a wearable which is designed to tackle conditions occurred due to poor access to sunlight and time shifts. It is worn as a pair of glasses and gives off blue light to mimic sunlight, apparently controlling melatonin production.

Light therapy can be difficult to achieve while travelling or at work. As a result, Pocket Sky enables patients to harness the benefits of light therapy with the use of a small wearable. Rising demand for wearables in healthcare is expected to accelerate the adoption of this wearable light therapy for the treatment of the seasonal affective disorder. This, in turn, will offer an opportunity for the global seasonal affective disorder therapeutics market.

Global Seasonal Affective Disorder Therapeutics Market- Segmentation

By Disorder Type

Unipolar Disorder

Bipolar Disorder

By Treatment Type

Medications

Light Therapy

Others

Selective Serotonin Reuptake Inhibitors (SSRIs)

Monoamine Oxidase Inhibitors (MAOIs)

Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)

Others

Global Seasonal Affective Disorder Therapeutics Market– Segment by Region

North America          

US

Canada

Europe

Germany

UK

France

Spain

Italy

Rest of Europe

Asia-Pacific    

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Company Profiles

AbbVie Inc.

Active Wearables GmbH

Aura Day Light

Bristol-Myers Squibb Co.

Carex Health Brands

Eli Lilly & Co.

F. Hoffmann-La Roche AG

GlaxoSmithKline plc

H. Lundbeck A/S

Koninklijke Philips N.V.

Lucimed SA

Mylan N.V.

Novalogy, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/seasonal-affective-disorder-therapeutics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

[businessliveme]

Japan May Ease Entry Bans; Asian PMIs Show Fallout: Virus Update

(Bloomberg) — Japan is considering easing entry restrictions on people from four countries in Asia-Pacific that have had success in taming coronavirus outbreaks, according to a newspaper report. Asia’s factory managers remained downbeat in May, even as economies start to reopen.

Wuhan, where the novel coronavirus was first reported, reported no asymptomatic cases on Sunday for the first time since the city started publishing the data. Britain’s government is reported to be working on a stimulus package to lessen the depth of an economic downturn.

U.S. stock futures fell as investors weighed violent protests that have stoked concerns about new infection outbreaks, while Asian equities were largely mixed in early Monday trading.

Key Developments:

Virus Tracker: Cases top 6.1 million; deaths exceed 371,000

China Is Trying to Salvage Its Bruised Electric-Car Industry

Bodies Left on Hospital Beds as Virus Overwhelms Mumbai

How China Tested 11 Million People for Virus in Just Two Weeks

Protests hammer U.S. cities struggling to open after lockdown

Testing on kids is a nervous next step on way to vaccine

Lockdowns push baby boombers to embrace online banking

Subscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click VRUS on the terminal for news and data on the coronavirus. For a look back at this week’s top stories from QuickTake, click here.

Weak PMIs Show Continued Virus Fallout (9:30 a.m. HK)

Purchasing managers indexes for South Korea, Japan and Taiwan fell, according to data released by IHS Markit on Monday. Readings for Vietnam, Malaysia, Thailand and the Philippines improved but remain below 50, the dividing line between contraction and expansion.

The reports add to gloomy data from China, where the official manufacturing PMI published Sunday slipped to a worse-than-expected 50.6.

Japan Weighs Eased Entry Limits: Yomiuri (7:52 a.m. HK)

Japan’s government may relax entry restrictions on people from Thailand, Vietnam, Australia and New Zealand amid signs that coronavirus infections have fallen in those countries, Yomiuri said, citing government officials.

Entry limits may be relaxed as early as in summer, the newspaper reported Sunday. The visitors would be required to carry documentation showing that they had tested negative for the virus before leaving their countries, and would need to be re-tested when they arrive in Japan, according to the report.

U.K. Mulls New Stimulus: FT (6:30 a.m. HK)

The U.K. government is preparing an economic stimulus package to be unveiled in July as it steps up attempts to lessen the depth of the recession caused by the coronavirus pandemic, the Financial Times reported, citing unidentified officials.

Chancellor of the Exchequer Rishi Sunak is working on proposals to invest in training programs, infrastructure and help for technology firms, it said. He will also encourage people back to work as the lockdown to limit the virus leads to a surge in unemployment.

The Treasury on Friday announced an incremental tapering of its job support program in a bid to avert a mass wave of unemployment.

World Bank Says Virus Hurt Palestinians (6:10 a.m. HK)

The Palestinians will need outside help to overcome a poor economic outlook and widening budget deficit made far worse by the Covid-19 pandemic, according to a new World Bank report.

Facing a growth slowdown and sizable deficit, the West Bank and Gaza Strip could see output shrink between 7.6% and 11%, depending on how fast the economy recovers from the virus, the World Bank said. In total, more than 430 cases were reported across the West Bank and Gaza, with three deaths.

Cuomo Links Covid, Protests (5:55 p.m. NY)

New York Governor Andrew Cuomo made a connection between the lockdown triggered by Covid-19 and the eruption of violence over the death of a black man in police custody as he reported the fewest news deaths since the outbreak’s peak in April.

“It’s not a coincidence that the unrest happens in the middle of the pandemic, right?” Cuomo told reporters in Albany. “Those are not separate situations. There’s tremendous stress on everyone.”

Cuomo said the actions of individual New Yorkers in wearing masks and practicing social distancing had brought the daily death toll down from nearly 800 at the peak. “Who changed society to deal with this virus? The people did it,” he said.

EU Tests Business Tax for Virus Fund (5:30 p.m. NY)

The European Union’s budget commissioner wants member states to back new taxes, including a levy on big companies for access to the single market, to help fund the recovery from the economic effects of the coronavirus, the Financial Times reported.

In an interview, Commissioner Johannes Hahn said the tax would be part of a package to cover the EU’s proposed 750 billion euro ($675 billion) fund to help with rebuilding. Hahn said there was no alternative but to give the European Commission new measures of collecting revenue to service debt it would take on under the recovery plan.

Among the obstacles to be overcome is opposition among so-called frugal countries — Austria, Denmark, the Netherlands and Sweden, the newspaper said. Hahn is from Austria.

U.S. Sends Brazil Drug Touted by Trump (4:30 p.m. NY)

The U.S. is sending Brazil 2 million doses of hydroxychloroquine, a malaria drug touted by President Donald Trump, and 1,000 ventilators, the White House said.

The drug will be used by Brazil’s nurses, doctors, and health-care professionals to fight Covid-19 and to treat Brazilians who become infected. The Food and Drug Administration said the drug should be used in a hospital setting.

The two countries will cooperate on controlled clinical trials to help evaluate the safety and efficacy of the drug for both prophylaxis and the early treatment of the coronavirus, the White House said.

U.S. Cases Rose 1.1%, Slowest Since May 26 (4 p.m. NY)

U.S. cases increased 1.1% from the same time Saturday, to 1.78 million, according to data collected by Johns Hopkins University and Bloomberg News. The national increase was below the average daily increase of 1.3% over the past week, and the lowest since May 26. Deaths rose 0.7% to 104,081.

New York reported 1,110 new cases, for a total of 370,770, with 57 new deaths, to total 23,905. The state had 299 daily deaths on May 2 and 799 in early April.

New Jersey had 868 new cases for a total of 160,445 and 66 deaths, raising the total to 11,698, Governor Phil Murphy said.

California reported 3,705 new cases, the biggest one-day rise, to reach a total of 110,583, while new deaths fell for a third day, to 57, for a total of 4,213.

Pennsylvania had 511 new cases, bringing the statewide total to 71,926, and 18 new deaths for a total of 5,555.

Maryland reported 763 new cases, for a total of 52,778, with 21 deaths, for a total of 2,411, as Governor Larry Hogan said the rate of positive cases fell to 10.9% from a 26.9% peak on April 17.

Chicago Mulls Delay of Reopening (3:15 p.m. NY)

Chicago may postpone its partial easing of the Covid-19 shutdowns this week after violent protests over the death of George Floyd left devastating wreckage, Mayor Lori Lightfoot said Sunday.

The city was set to start reopening on Wednesday then add more city services and some parks on June 8, but Lightfoot said she’s consulting with the commissioner of public health, police superintendent and others to make a determination on the plan.

Access to Chicago’s downtown and central business district is restricted, and public transit into the loop has been suspended.

Europe’s Hot Spots Ease Lockdowns (2 p.m. NY)

As coronavirus death tolls stabilize in some European countries such as Italy, new cases continue to rise steadily elsewhere, particularly in the U.K. Still, governments are under pressure to let shops, factories and services reopen as the European Commission predicts the virus will wipe out 7.7% of the economy this year.

The U.K. will let some schools, outdoor markets and car showrooms open on Monday under social-distancing guidelines, along with some competitive sports, including horse racing. Italy, with the world’s third-highest death toll, is also moving with caution after protests supporting the lifting of restrictions erupted in Rome and Milan.

Europe’s biggest economy, Germany, is only beginning to ease curbs but is planning on holding the world’s largest book fair in October under a strict hygienic regime. Greece will allow visitors from more nations to visit the country from June 15.

Israel Starts Antibody Testing (1:50 p.m. NY)

Israel began serological testing for coronavirus, health ministry officials said, amid concerns a new wave of the outbreak may be starting. The first tests were conducted on foreign workers, and will soon expand to the general population, the officials said. The tests determine how much of the population has already been infected.

The country reported 53 new cases, bringing the total to 17,071, including 285 fatalities. New infections rose following the recent easing of lockdown restrictions.

China Sends Masks, Tests to Africa (12:51 p.m. NY)

China will supply as many as 30 million coronavirus test kits, 10,000 ventilators and 80 million masks a month to Africa to help deal with the pandemic, South African President Cyril Ramaphosa said in a briefing to reporters broadcast on online Sunday.

Ramaphosa held talks with Chinese President Xi Jinping about securing the supplies last week, he said. State-owned carriers South African Airways, Ethiopian Airlines Group and Kenya Airways Plc will deliver the shipments.

N.Y. Daily Deaths Fall to 56 (12:20 p.m. NY)

New York reported 56 new deaths, Governor Andrew Cuomo said Sunday at a press briefing. It’s the sixth straight day with under 75 fatalities.

“This reduction in the number of deaths is tremendous progress from where we were,” Cuomo said in Albany. “We have gone through hell and back, but we are on the other side.”

The governor noted daily deaths peaked at almost 800 in early April.

Italy Extends Trend of Fewer Cases (12:05 p.m. NY)

Italy’s new cases remained on a declining trend on Sunday, with 355 more people affected, down from 416 a day earlier. Daily deaths were 75, down from 111 on Saturday. A total of 33,415 fatalities have been reported, with 16,112 — 48% — in Lombardy, the region around Milan that was one of the original virus epicenters in Europe.

The government has said improving data means it will be possible to open borders and lift a ban on inter-regional travel on Wednesday. Some regional authorities vow to keep borders closed to people from regions with high case levels, like Lombardy, the area around Milan, which accounts for 38% of total cases in Italy.

NYC Finance Jobs Tested (11:30 a.m. NY)

New York City’s finance industry won’t recover from the devastation wrought by Covid-19 until 2026, according to an analysis by software firm ThinkIQ that ranks U.S. employment markets.

The region lost about 8% of its finance jobs this year, down from a peak of more than 800,000 in August. Coronavirus isn’t the culprit in all of the cuts. But the lockdown to stem the sppread caused a domino effect on everything from rents to mortgage payments.

ThinkIQ predicts employment will be almost back to 2019 levels in six years. Employment in the leisure and hospitality arena is to reach about 90% of its 2019 level by 2026, the latest year in the forecast.

The post Japan May Ease Entry Bans; Asian PMIs Show Fallout: Virus Update appeared first on Businessliveme.com.

from WordPress https://ift.tt/3cm5ZIP via IFTTT

[renegadeelectrics]

Elevate your systems with Renegade Electrics' expert Control Panel Design in New Zealand. Our precision-crafted designs ensure seamless and efficient operations, tailored to your specific needs. Trust us to redefine your control experience with innovative solutions. Choose Renegade Electrics for top-tier Control Panel Designs, delivering excellence in every detail across New Zealand.

[market-insider]

Bariatric Surgery Devices Market Size Worth $2.8 Billion By 2022

The global bariatric surgery devices market is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research, Inc. The growing incidence rate of obesity has led to many government initiatives at regional as well as global level to increase the awareness related to obesity and undertake various incidence curbing action plans. For instance, the South Wales government launched the NSW Healthy Eating and Active Living Strategy 2013-2018 for preventing obesity.

In addition, to strategic planning, the governments of developed nations are also funding universities to design strategic interventions to control the rising obesity. For the year 2014, New Zealand invested USD 40 million for its Healthy Families NZ anti-obesity initiative. Moreover, industry players are also trying to tackle the rising problem of obesity by launching new products. In February 2017, a startup company, Allurion Technologies, located in Massachusetts, U.S. filed a regulatory filing to report the USD 19 million raised amount out of the target of USD 27 million. The funds were intended to use for the development non-endoscopic gastric balloon, Ellipse. This device is in the form of capsule which when swallowed, is inflated in the stomach and deflates after months and is passed out without the need for anesthesia for its removal. This device is anticipated to revolutionize the bariatric surgery devices market due to its ease of use over the forecast period

The demand for non-invasive surgeries is also increasing, as non-invasive surgeries save time, cost, and decrease hospital stay. Governments are also encouraging the use of more incisionless surgeries in order to decrease the cases of infection. For instance, in July 2015, the FDA approved a balloon device, where the balloon is directly swallowed using a sterile solution.

For More Details Please Visit @: https://www.grandviewresearch.com/industry-analysis/bariatric-surgery-devices-industry

Further Key Findings from the Report Suggest:

Gastric bypass surgery     dominated the market in 2014 due to its early adoption since 1960 and the     fact that it is the combination of both restrictive and malabsorptive     procedures.

The sleeve gastrectomy     surgery is expected to witness rapid rise in demand owing to, the     procedure's incision-less nature. The fact that the procedure does not     involve re-routing the intestine is also likely to drive segment growth.     With the FDA approval of ReShape balloon, there has been a recent FDA     filing for Ellipse device, which is swallowed and gets excreted naturally     after four months.

North America was the     largest regional market owing to the presence of market players     introducing innovative technologies to improve patient care.

Favorable government     initiatives are also expected to play pivotal roles in the European market     growth. For instance, the German Federal Ministry of Education and Research     (BMBF) formed two funding research programs namely the Competence Network     Obesity and Integrated Research and Treatment Center (IFB) Adiposity     Diseases with budgets allocated at around USD 26 million for 2012-2015.

Asia Pacific followed North     America in terms of obesity and overweight prevalence. This coupled with     the presence of large untapped opportunities is expected to help the Asia     Pacific bariatric surgery market register the fastest growth over the     forecast period.

Some key players of this     market include Covidien Plc, Intuitive Surgical Inc., TransEnterix Inc.,     Allergan Inc., USGI Medical Inc., Semiled Ltd., Cousin Biotech, GI     Dynamics Inc., Johnson and Johnson and Mediflex Surgical Product.

Grand View Research has segmented the bariatric surgery devices market report on the basis of procedures:

Procedure Outlook (Revenue, USD Million, 2012 - 2022)

Adjustable Gastric Band     (AGB)

Vertical Sleeve Gastrectomy     (VSG)

Roux-en-Y Gastric Bypass     (RYGB)

Biliopancreatic Diversion     with a Duodenal Switch (BPD-DS)

Regional Outlook (Revenue, USD Million, 2012 - 2022)

 U.S. and Canada

 Germany

 UK

 France

 Japan

 China

 India

 Brazil

 Mexico

 South Africa

[industrystudyreport]

Automotive Camera Module Market Development Opportunities, Growth Trends, and Forecast, 2022

Global automotive camera module market is expected to grow at a significant CAGR of 21.2% in the upcoming period as the scope and its applications are rising enormously across the globe. Automotive camera module comprises image sensors that help in preclusion of accidents, record driver’s inclination, and offer enhanced driving experience. 

The factors that are playing a major role in the growth of market are growing awareness among insurance companies regarding safety measures, high impact of new car assessment program (NCAP), and growing demand for luxury vehicles. However, the high cost of advanced driver assistance system (ADAS) may restrain overall market growth in the years to come. Automotive camera module market is segmented based on product type, technology, vehicle type, application, and region. 

Driver support cameras and driver assistance cameras are the product types that could be explored in the automotive camera module in the forecast period. The driver assistance camera sector accounted for the substantial market share of the automotive camera module and is estimated to lead the overall market in the years to come. 

Based on technology, thermal, infrared, and digital could classify automotive camera module in the forecast period. The digital sector accounted for the substantial market share of the automotive camera module in terms of volume and is estimated to lead the overall market in the years to come. In addition, the infrared sector is estimated to grow at the fastest pace in the years to come. 

Get Sample Copy of this Report @

https://www.millioninsights.com/industry-reports/automotive-camera-module-market/request-sample

Electric vehicles, passenger vehicles, and commercial vehicles are the vehicle types that could be explored in the automotive antenna in the forecast period. Electric vehicle sector comprises hybrid vehicles, battery-operated electric vehicles, and plug-in hybrid vehicles. Passenger vehicles comprise sports utility vehicles, hatchback cars, multi-purpose vehicles, and sedans. Commercial vehicles comprise heavy and lightweight vehicles. 

The market may be categorized based on applications like blind spot detection (BSD), lane departure warning, adaptive cruise control (ACC), pedestrian detection, road sign recognition systems, park assist, night vision, driver monitoring, and the others that could be explored in the automotive camera module in the forecast period. The lane departure-warning sector is estimated to grow at the highest CAGR in the years to come. Also, park assist sector is estimated to grow at the fastest pace in the years to come. 

Automotive camera module market is segmented geographically into Americas (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific (India, China, Japan, New Zealand, and Australia), Middle East (UAE, Saudi, and Qatar) and Africa (South Africa). 

Globally, North America accounted for the substantial market share of the automotive camera module and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the presence of key manufacturers in the region and the rising use of enhanced technology. 

Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period. The aspects that could be ascribed to the growth comprise growing demand from consumers for technologically enhanced vehicles. The key players of the automotive camera module market are Continental AG, Robert Bosch Gmbh, Valeo, Delphi Automotive PLC, and Autoliv Inc. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition. 

Browse Related Category Market Reports @ https://industriesstudyreport.blogspot.com/

[shristipbi]

Influenza Vaccines Market  Growth, Analysis, Key Players, and Forecast to 2025

“The Global Influenza Vaccines Market is expected to reach US$ 6,679.8 Mn by 2025 owing to the increasing prevalence of influenza”

 The global influenza vaccines market is expected to reach US$ 6,679.8 Mn by 2025. Influenza is usually known as “flu” or “seasonal flu” triggered by influenza virus. The symptoms of influenza can be mild to severe ranging from fever to pneumonia. The global influenza vaccines market is driven by the rising prevalence of influenza. According to World Health Organization influenza affects about 3 to 5 million people globally of which there are cases of 290, 000 to 650, 000 respiratory deaths due to it. This virus generally spread through the air by coughing and sneezing or touching surfaces contaminated by a virus. WHO every year forecasts few strains which are expected to circulate in following year, that motivates pharmaceutical companies to develop influenza vaccine against these stains. Strict and mandatory government’s rule to take influenza vaccine as a preventive measure among different age group people is fueling the growth of global influenza vaccines market. Moreover reduced healthcare burden due to influenza vaccination expected to propel the market for influenza vaccine. However, Influenza vaccine made in a year may not be effective in following year owing to evolving nature of influenza virus, in healthy individual influenza vaccine is modestly effective, sometimes new strain or overlooked strain become prevalent in that season, and product recalls which may hamper the uptake and growth influenza vaccine market.

 Global influenza vaccines market is segmented on the basis of vaccine type, strain type, formulation type, distribution channel, and region.

 Request for Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=16918

  Killed or Inactivated Vaccines Dominate the Global Influenza Vaccines Market

Based on the vaccine type, global influenza vaccines market is segmented into killed or inactivated and live vaccines. Killed or inactivated vaccines dominated the global influenza vaccines market. They produce strong immune response by holding inactivated genomic component and the surface of the virus which is exposed to the antigens that are important for strong immune response. Initiation of strong and long-lasting immune response will enhance the growth of this segment.

 North America Leads the Global Influenza Vaccines Market

PBI’s global influenza vaccines market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global influenza vaccines market through 2014-2018 and expected to dominate over 2019-2025 owing to increase in prevalence of flu over there. The flu has resulted in 9.3 million to 49 million illnesses each year in the United States since 2010. It is estimated that the flu results in 31.4 million outpatient visits and more than 200,000 hospitalizations each year. Moreover, increase in research and development for new vaccines, and improved healthcare facilities are also aiding in the growth of the influenza vaccines market. Increased government support to stop the disease and to fine preventive measures is also bolstering the growth of influenza vaccines market in North America. Europe influenza vaccines market accounted for a significant share in global influenza vaccines market due to its increase in its prevalence among the European population. According to European Centre for Disease Prevention and Control around 60 % of European populations are affected with influenza virus. Moreover, development in healthcare infrastructure, and increase in disposable income in countries such as U.K, Germany etc. are also streaming the market growth in Europe region. Asia Pacific influenza vaccines market expected to grow significantly rate due to their emerging economies, increase in the prevalence of influenza virus, development of healthcare infrastructure, and technological advancements. As per Integrated Disease Surveillance Program (IDSP) under the National Centre for Disease Control a total of 38 811 laboratories confirmed cases and 2266 deaths were reported in the year 2017 in India.

Launch of newer treatment therapies, and strategic alliances are the key strategies adopted by market players

Global Influenza Vaccines market further reveals that the key player’s increasingly adopting strategies such as launch of newer treatment therapies, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

 Ø  For instance, in August 2015, CSL announced an agreement to acquire the influenza vaccines business of Novartis for US$275 million.

Ø  Furthermore, in July 2017, Sanofi bought the vaccine biotech Protein Sciences for $750 million.

Ø  Moreover, in October 2019, GlaxoSmithKline Biologicals got approval for their influenza virus vaccine “Fluarix Quadrivalent” by the FDA.

Ø  Additionally, in October 2019, Seqirus Pty. Ltd. got FDA’s approval for their influenza virus vaccine “Afluria Quadrivalent”.

 Key player’s profiles in the report are GlaxoSmithKline plc., Seqirus (CSL Limited), AstraZeneca, Sanofi Pasteur Inc., Sinovac Biotech Ltd., Novavax, Inc., DAIICHI SANKYO COMPANY, LIMITED., Mitsubishi Tanabe Pharma., Protein Sciences Corporation.

 Precision Business Insights (PBI) in its report titled “Global Influenza Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 Detailed Segmentation

 By Vaccine Type

·         Killed or Inactivated Vaccine

·         Live Vaccine

 By Strain Type

·         Trivalent Influenza Vaccine

·         Quadrivaleant Influenza Vaccine

 By Formulation Type

·         Injections

·         Nasal Sprays

 By Distribution Channel

·         Government Immunization programmes

·         Non-Governmental Organizations (NGOs)

·         Hospitals

·         Clinics

 Geography

 o     North America

·         US

·         Canada

o     Europe

·         Germany

·         France

·         UK

·         Italy

·         Spain

·         Russia

·         Poland

·         Rest of Europe

o     Asia-Pacific

·         Japan

·         China

·         India

·         Australia & New Zealand

·         ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

·         South Korea

·         Rest of Asia-Pacific

o     Latin America

·         Brazil

·         Mexico

·         Argentina

·         Rest of Latin America

o     Middle East and Africa (MEA)

·         Gulf Cooperation Council (GCC) Countries

·         Israel

·         South Africa

·         Rest of MEA

 For more information: https://www.precisionbusinessinsights.com/market-reports/global-influenza-vaccine-market/

  About Us:

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

 Contact Us:

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[researchreportinsight]

Automotive Camera Module Market Product, Application, End-User Industry, and Geography - Global Forecast to 2022

10 October 2019 - Global Automotive Camera Module Market is expected to grow at a significant CAGR of 21.2% in the upcoming period as the scope and its applications are rising enormously across the globe. Automotive camera module comprises image sensors that help in preclusion of accidents, record driver’s inclination, and offer enhanced driving experience.

The factors that are playing a major role in the growth of market are growing awareness among insurance companies regarding safety measures, high impact of new car assessment program (NCAP), and growing demand for luxury vehicles. However, the high cost of advanced driver assistance system (ADAS) may restrain overall market growth in the years to come. Automotive camera module market is segmented based on product type, technology, vehicle type, application, and region.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/automotive-camera-module-market

Driver support cameras and driver assistance cameras are the product types that could be explored in the automotive camera module in the forecast period. The driver assistance camera sector accounted for the substantial market share of the automotive camera module and is estimated to lead the overall market in the years to come.

Based on technology, thermal, infrared, and digital could classify automotive camera module in the forecast period. The digital sector accounted for the substantial market share of the automotive camera module in terms of volume and is estimated to lead the overall market in the years to come. In addition, the infrared sector is estimated to grow at the fastest pace in the years to come.

Electric vehicles, passenger vehicles, and commercial vehicles are the vehicle types that could be explored in the automotive antenna in the forecast period. Electric vehicle sector comprises hybrid vehicles, battery-operated electric vehicles, and plug-in hybrid vehicles. Passenger vehicles comprise sports utility vehicles, hatchback cars, multi-purpose vehicles, and sedans. Commercial vehicles comprise heavy and lightweight vehicles.

The market may be categorized based on applications like blind spot detection (BSD), lane departure warning, adaptive cruise control (ACC), pedestrian detection, road sign recognition systems, park assist, night vision, driver monitoring, and the others that could be explored in the automotive camera module in the forecast period. The lane departure-warning sector is estimated to grow at the highest CAGR in the years to come. Also, park assist sector is estimated to grow at the fastest pace in the years to come.

Automotive camera module market is segmented geographically into Americas (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific (India, China, Japan, New Zealand, and Australia), Middle East (UAE, Saudi, and Qatar) and Africa (South Africa).

Globally, North America accounted for the substantial market share of the automotive camera module and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the presence of key manufacturers in the region and the rising use of enhanced technology.

Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period. The aspects that could be ascribed to the growth comprise growing demand from consumers for technologically enhanced vehicles. The key players of the automotive camera module market are Continental AG, Robert Bosch Gmbh, Valeo, Delphi Automotive PLC, and Autoliv Inc. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.

Market Segment:

Key Applications

• Dash Camera

• Backup

• Surround

• ADAS

Key Regions

• North America

• Europe

• Asia Pacific

• Middle East and Africa

• South America

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/automotive-camera-module-market/request-sample